Skip to content

Etest Grepafloxacin

by Ab Biodisk Sweden 510(k)

510(k) K980773

Product code JWY

Overview

The Etest Grepafloxacin is a manual antimicrobial susceptibility test system designed for determining the minimum inhibitory concentration (MIC) of grepafloxacin against bacterial isolates. It falls under the category of Manual Antimicrobial Susceptibility Test Systems, utilising gradient diffusion strips to measure bacterial resistance or susceptibility to the antibiotic grepafloxacin.

This device is supplied as a single-use test system and is intended for use in microbiology laboratories. It adheres to regulatory standards under FDA 510(k) clearance (K980773) and is classified as a Class II medical device under regulation 866.1640. The test strips are non-sterile and must be handled in accordance with standard microbiological practices, ensuring proper storage and handling to maintain accuracy and reliability.

Summary written by AI from registry data, 1 Oct 2026.Not verified

About this summary

This description and any FAQs on this page were generated automatically and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them.

Regulatory status

as of 25 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK980773 Date18 May 1998ClearedStatusActive

Coverage

1 jurisdiction

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Not covered

United States — FDA 510(k) Active

Recalls: none on record (FDA, checked 6 Oct 2026)

Specification

510(k) · synced 6 Oct 2026

510(k) Number
FDA Product Code
JWY
Device Class
Class II
Regulation
21 CFR Part 866.1640
Advisory Committee
Microbiology
FDA Decision
SESE Substantially Equivalent

Other devices from Ab Biodisk

See all devices from Ab Biodisk →

Questions

  • What is the ETEST Grepafloxacin used for?

    The ETEST Grepafloxacin is a manual antimicrobial susceptibility test system designed to determine the minimum inhibitory concentration (MIC) of grepafloxacin against bacterial isolates. By measuring bacterial resistance or susceptibility through gradient diffusion strips, it helps microbiology labs assess how effectively grepafloxacin can inhibit bacterial growth, guiding appropriate antibiotic treatment decisions.

  • How is the ETEST Grepafloxacin supplied and intended for use?

    The ETEST Grepafloxacin is supplied as a single-use test system, meaning each strip is intended for one test only. It is specifically designed for use in microbiology laboratories to perform antimicrobial susceptibility testing. The non-sterile nature of the strips requires adherence to standard microbiological practices during handling to ensure accurate and reliable results.

  • Is the ETEST Grepafloxacin sterile, and how should it be stored?

    The ETEST Grepafloxacin strips are non-sterile, so they must be handled in accordance with standard microbiological practices to prevent contamination. Proper storage is critical to maintaining the integrity and accuracy of the test results. Store the strips in a cool, dry place, away from direct sunlight and extreme temperatures, following the manufacturer’s guidelines to preserve their effectiveness until use.

  • What regulatory clearance does the ETEST Grepafloxacin hold?

    The ETEST Grepafloxacin holds FDA 510(k) clearance under the reference number K980773. This clearance indicates that the device has been deemed substantially equivalent to a legally marketed predicate device and is classified as a Class II medical device under regulation 866.1640. This classification reflects its role in antimicrobial susceptibility testing within microbiology.

  • Can the ETEST Grepafloxacin strips be reused?

    No, the ETEST Grepafloxacin strips are designed for single-use only. Reusing them could compromise the accuracy of the MIC results due to potential contamination or degradation of the gradient diffusion strip. Always use a fresh strip for each test to ensure reliable and reproducible outcomes in determining bacterial susceptibility to grepafloxacin.

Properties & raw data

Show properties, registry sources and raw records

Sources (1)

  • FDA 510(k) K980773 24 fields · synced 6 Oct 2026